The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123119005 12311900 5 F 20160417 20160816 20160427 20160822 EXP US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-031282 BRISTOL MYERS SQUIBB 65.03 YR M Y 90.70000 KG 20160822 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123119005 12311900 1 PS NIVOLUMAB NIVOLUMAB 1 Intravenous (not otherwise specified) 3 MG/KG, UNK; DAYS 1 AND 15 OF EACH 28 DAY CYCLE 125554 3 MG/KG
123119005 12311900 2 SS NIVOLUMAB NIVOLUMAB 1 Intravenous (not otherwise specified) 3 MG/KG, UNK 125554 3 MG/KG
123119005 12311900 3 SS NIVOLUMAB NIVOLUMAB 1 Intravenous (not otherwise specified) 3 MG/KG, UNK 125554 3 MG/KG
123119005 12311900 4 SS PACLITAXEL ALBUMIN PACLITAXEL 1 Intravenous (not otherwise specified) 125 MG/M2, QD; DAYS 1, 8 AND 15 OF A 28 DAY CYCLE 0 125 MG/M**2 QD
123119005 12311900 5 SS PACLITAXEL ALBUMIN PACLITAXEL 1 Intravenous (not otherwise specified) 125 MG/M2, UNK 0 125 MG/M**2 QD
123119005 12311900 6 SS PACLITAXEL ALBUMIN PACLITAXEL 1 Intravenous (not otherwise specified) 125 MG/M2, QD 0 125 MG/M**2 QD
123119005 12311900 7 SS GEMCITABINE HYDROCHLORIDE. GEMCITABINE HYDROCHLORIDE 1 Unknown 1000 MG/M2, UNK; DAYS 1, 8 AND 15 OF A 28 DAY CYCLE 0 1000 MG/M**2 QD
123119005 12311900 8 SS GEMCITABINE HYDROCHLORIDE. GEMCITABINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 1000 MG/M2, QD 0 1000 MG/M**2 QD
123119005 12311900 9 SS GEMCITABINE HYDROCHLORIDE. GEMCITABINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 1000 MG/M2, QD 0 1000 MG/M**2 QD
123119005 12311900 10 SS CARBOPLATIN. CARBOPLATIN 1 Unknown 0
123119005 12311900 11 C ZYLOPRIM ALLOPURINOL 1 Oral 100 MG, UNK U 0 100 MG
123119005 12311900 12 C ATENOLOL. ATENOLOL 1 Unknown 50 MG, QD U 0 50 MG TABLET QD
123119005 12311900 13 C ATENOLOL. ATENOLOL 1 Unknown 100 MG, QD U 0 100 MG TABLET QD
123119005 12311900 14 C LIPITOR ATORVASTATIN CALCIUM 1 Oral 20 MG, QD U 0 20 MG TABLET QD
123119005 12311900 15 C KLONOPIN CLONAZEPAM 1 Oral 0.5 MG, QD U 0 .5 MG TABLET QD
123119005 12311900 16 C MOTRIN IBUPROFEN 1 Oral 400 MG, TID U 0 400 MG TABLET TID
123119005 12311900 17 C LANTUS INSULIN GLARGINE 1 Subcutaneous 40 U, PRN U 0 40 DF INJECTION
123119005 12311900 18 C LANTUS INSULIN GLARGINE 1 Subcutaneous 20 U, UNK U 0 20 DF INJECTION
123119005 12311900 19 C EMLA LIDOCAINEPRILOCAINE 1 Unknown U 0 CREAM
123119005 12311900 20 C GLUCOPHAGE METFORMIN HYDROCHLORIDE 1 Oral 500 MG, BID U 0 500 MG TABLET BID
123119005 12311900 21 C REMERON MIRTAZAPINE 1 Oral 7.5 MG, QD U 0 7.5 MG TABLET QD
123119005 12311900 22 C ZOFRAN ONDANSETRON HYDROCHLORIDE 1 Oral 8 MG, PRN U 0 8 MG TABLET
123119005 12311900 23 C ACTOS PIOGLITAZONE HYDROCHLORIDE 1 Oral 45 MG, QD U 0 45 MG TABLET QD
123119005 12311900 24 C BACTRIM DS SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 0.5 MG, PRN U 0 .5 MG
123119005 12311900 25 C XANAX ALPRAZOLAM 1 Oral 0.5 MG, PRN U 0 .5 MG
123119005 12311900 26 C KEFLEX CEPHALEXIN 1 Oral 500 MG, Q6H U 0 500 MG QID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123119005 12311900 1 Pancreatic carcinoma
123119005 12311900 4 Pancreatic carcinoma
123119005 12311900 7 Pancreatic carcinoma
123119005 12311900 10 Pancreatic carcinoma
123119005 12311900 11 Product used for unknown indication
123119005 12311900 12 Product used for unknown indication
123119005 12311900 14 Product used for unknown indication
123119005 12311900 15 Product used for unknown indication
123119005 12311900 16 Product used for unknown indication
123119005 12311900 17 Product used for unknown indication
123119005 12311900 19 Product used for unknown indication
123119005 12311900 20 Product used for unknown indication
123119005 12311900 21 Product used for unknown indication
123119005 12311900 22 Product used for unknown indication
123119005 12311900 23 Product used for unknown indication
123119005 12311900 24 Urinary tract infection
123119005 12311900 25 Product used for unknown indication
123119005 12311900 26 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
123119005 12311900 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
123119005 12311900 Dehydration
123119005 12311900 Diarrhoea
123119005 12311900 Orthostatic hypotension

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123119005 12311900 1 20160204 0
123119005 12311900 2 20160331 0
123119005 12311900 3 20160602 0
123119005 12311900 4 20160204 0
123119005 12311900 5 20160331 0
123119005 12311900 6 20160602 0
123119005 12311900 7 20160204 0
123119005 12311900 8 20160331 0
123119005 12311900 9 20160602 0
123119005 12311900 18 20160418 0
123119005 12311900 26 20160418 0

Execution Time: 0.0098679065704346 seconds (ucode:5238074). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.